No basis for buyout; it's a rumor! Furthermore, $130-$150 @ share is beyond stupidity. Look at BMRN's portfolio and then tell me if this were all true based on the rumor buyout price, what would be the payback in terms of years for Roche? Somebody may buy BMRN but not at these nonsensical rumored prices. The payback in years is beyond commonsense.